The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Research
Categorie
Archives
These are days of R&D partnership in the health sector. The 9th edition of AFSSI Connexions will take place on July 5/6 in Lyon, France. Two days of congress and convention networking, a true annual french marketplace for R&D in Life Sciences! Several plenary...
Non-alcoholic liver disease (NAFLD) is considered the hepatic manifestation of the metabolic syndrome (which includes abdominal obesity, hyperglycemia, dyslipidemia and hypertension), and the leading cause of liver disease. NAFLD, like the metabolic syndrome, is a...
The General Assembly of the AFSSI was held on April 8th. On this occasion, Anne Abot, scientific director of Enterosys, was elected to the board of directors along with representatives of two other companies: Cell&Co and Vibiosphen. Their objective is to bring...
As a non-profit association which brings together industry and academic stakeholders, the PRI employs a collaborative approach to developing and sharing Regulatory Science expertise for the development of microbiome-based medicinal products. Like Enterosys, the PRI...
PERSONALIZED PREDICTION OF COGNITIVE FUNCTIONS BY THE HUMAN MICROBIOTA CREATE TOOLS TO TREAT NEUROCOGNITIVE DISORDERS The deterioration of cognitive functions is one of the main threats to the world population, due to the increase in life expectancy. The intestinal...